RE: RE: better & better Not to rain on anyone's parade, but I have been down this path before with PRP. I bought in several years ago when the backlogs were substantial and it looked like share price appreciation was imminent--it never happened. The problem lies in the fact the company never turns a profit. Are they selling their technologies at any cost in order to create sales? Looks good when the sales roll in, but at what cost to them. Improved profit margins are key. I continue to hold but with little faith